A reduction in skeletal muscle
fatty acid oxidation (FAO), manifested as a reduction in mitochondrial content and (or) FAO within mitochondria, may contribute to the development of
insulin resistance. n-3
polyunsaturated fatty acids (PUFA) have been observed to increase the capacity for FAO and improve
insulin sensitivity. We used the fat-1 mouse model, a transgenic animal capable of synthesizing
n-3 PUFA from n-6 PUFA, to examine this relationship. Fat-1 mice exhibited a approximately 20-fold decrease in the n-6/n-3 ratio in skeletal muscle, and plasma
glucose and the area under the
glucose curve were significantly (p < 0.05) lower in fat-1 mice during a
glucose challenge test. The improvement in whole-body
glucose tolerance in the fat-1 mouse was associated with a approximately 21% (p < 0.05) decrease in whole-muscle
citrate synthase (CS) activity (in red muscle only), without alterations in CS activity of isolated mitochondria (either red or white muscle; p > 0.05). These data suggest that the fat-1 mouse has decreased skeletal muscle mitochondrial content. However, the intrinsic ability of mitochondria to oxidize
fatty acids was not altered in the fat-1 mouse, as rates of
palmitate oxidation in isolated mitochondria from both red and white muscle were unchanged. Overall, this study demonstrates that a decrease in the n-6/n-3 ratio can enhance
glucose tolerance in healthy animals, independent of changes in mitochondrial content.